Finally, there are ongoing clinical trials in people with depression and an inflamed phenotype at baseline, testing if specific inflammatory cytokines such as IL-6 contribute to the pathogenesis of this type of “inflamed depression”, and if their clinical phenotype differs from people with “non-inflamed” depression (Khandaker et al., 2018). The gene discussed is IL6; the disease is depressive symptom measurement.